Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Front Public Health ; 10: 1030939, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36452944

RESUMEN

The COVID-19 pandemic and the high numbers of infected individuals pose major challenges for public health departments. To overcome these challenges, the health department in Cologne has developed a software called DiKoMa. This software offers the possibility to track contact and index persons, but also provides a digital symptom diary. In this work, the question of whether these can also be used for diagnostic purposes will be investigated. Machine learning makes it possible to identify infections based on early symptom profiles and to distinguish between the predominant dominant variants. Focusing on the occurrence of the symptoms in the first week, a decision tree is trained for the differentiation between contact and index persons and the prevailing dominant variants (Wildtype, Alpha, Delta, and Omicron). The model is evaluated, using sex- and age-stratified cross-validation and validated by symptom profiles of the first 6 days. The variants achieve an AUC-ROC from 0.89 for Omicron and 0.6 for Alpha. No significant differences are observed for the results of the validation set (Alpha 0.63 and Omicron 0.87). The evaluation of symptom combinations using artificial intelligence can determine the individual risk for the presence of a COVID-19 infection, allows assignment to virus variants, and can contribute to the management of epidemics and pandemics on a national and international level. It can help to reduce the number of specific tests in times of low labor capacity and could help to early identify new virus variants.


Asunto(s)
COVID-19 , Humanos , Recién Nacido , COVID-19/diagnóstico , COVID-19/epidemiología , Pandemias , Inteligencia Artificial , SARS-CoV-2 , Salud Pública
2.
Biomedicines ; 10(10)2022 Sep 24.
Artículo en Inglés | MEDLINE | ID: mdl-36289648

RESUMEN

The definitive diagnosis and early treatment of many immune-mediated inflammatory diseases (IMIDs) is hindered by variable and overlapping clinical manifestations. Psoriatic arthritis (PsA), which develops in ~30% of people with psoriasis, is a key example. This mixed-pattern IMID is apparent in entheseal and synovial musculoskeletal structures, but a definitive diagnosis often can only be made by clinical experts or when an extensive progressive disease state is apparent. As with other IMIDs, the detection of multimodal molecular biomarkers offers some hope for the early diagnosis of PsA and the initiation of effective management and treatment strategies. However, specific biomarkers are not yet available for PsA. The assessment of new markers by genomic and epigenomic profiling, or the analysis of blood and synovial fluid/tissue samples using proteomics, metabolomics and lipidomics, provides hope that complex molecular biomarker profiles could be developed to diagnose PsA. Importantly, the integration of these markers with high-throughput histology, imaging and standardized clinical assessment data provides an important opportunity to develop molecular profiles that could improve the diagnosis of PsA, predict its occurrence in cohorts of individuals with psoriasis, differentiate PsA from other IMIDs, and improve therapeutic responses. In this review, we consider the technologies that are currently deployed in the EU IMI2 project HIPPOCRATES to define biomarker profiles specific for PsA and discuss the advantages of combining multi-omics data to improve the outcome of PsA patients.

3.
Artículo en Alemán | MEDLINE | ID: mdl-35920847

RESUMEN

BACKGROUND AND GOALS: Even in the early phase of the COVID-19 pandemic, which took a very different course globally, there were indications that socio-economic factors influenced the dynamics of disease spread, which from the second phase (September 2020) onwards particularly affected people with a lower socio-economic status. Such effects can also be seen within a large city. The present study visualizes and examines the spatio-temporal spread of all COVID-19 cases reported in Cologne, Germany (February 2020-October 2021) at district level and their possible association with socio-economic factors. METHODS: Pseudonymized data of all COVID-19 cases reported in Cologne were geo-coded and their distribution was mapped in an age-standardized way at district level over four periods and compared with the distribution of social factors. The possible influence of the selected factors was also examined in a regression analysis in a model with case growth rates. RESULTS: The small-scale local infection process changed during the pandemic. Neighborhoods with weaker socio-economic indices showed higher incidence over a large part of the pandemic course, with a positive correlation between poverty risk factors and age-standardized incidence. The strength of this correlation changed over time. CONCLUSION: The timely observation and analysis of the local spread dynamics reveals the positive correlation of disadvantaging socio-economic factors on the incidence rate of COVID-19 at the level of a large city and can help steer local containment measures in a targeted manner.


Asunto(s)
COVID-19 , COVID-19/epidemiología , Factores Económicos , Alemania/epidemiología , Humanos , Pandemias , Factores de Riesgo , Factores Socioeconómicos
4.
Sensors (Basel) ; 17(12)2017 Nov 29.
Artículo en Inglés | MEDLINE | ID: mdl-29186080

RESUMEN

In the first hours of a disaster, up-to-date information about the area of interest is crucial for effective disaster management. However, due to the delay induced by collecting and analysing satellite imagery, disaster management systems like the Copernicus Emergency Management Service (EMS) are currently not able to provide information products until up to 48-72 h after a disaster event has occurred. While satellite imagery is still a valuable source for disaster management, information products can be improved through complementing them with user-generated data like social media posts or crowdsourced data. The advantage of these new kinds of data is that they are continuously produced in a timely fashion because users actively participate throughout an event and share related information. The research project Evolution of Emergency Copernicus services (E2mC) aims to integrate these novel data into a new EMS service component called Witness, which is presented in this paper. Like this, the timeliness and accuracy of geospatial information products provided to civil protection authorities can be improved through leveraging user-generated data. This paper sketches the developed system architecture, describes applicable scenarios and presents several preliminary case studies, providing evidence that the scientific and operational goals have been achieved.


Asunto(s)
Colaboración de las Masas , Sistemas de Computación , Desastres , Servicios Médicos de Urgencia , Medios de Comunicación Sociales , Factores de Tiempo
5.
Artículo en Alemán | MEDLINE | ID: mdl-26063521

RESUMEN

Healthcare is one of the business fields with the highest Big Data potential. According to the prevailing definition, Big Data refers to the fact that data today is often too large and heterogeneous and changes too quickly to be stored, processed, and transformed into value by previous technologies. The technological trends drive Big Data: business processes are more and more executed electronically, consumers produce more and more data themselves - e.g. in social networks - and finally ever increasing digitalization. Currently, several new trends towards new data sources and innovative data analysis appear in medicine and healthcare. From the research perspective, omics-research is one clear Big Data topic. In practice, the electronic health records, free open data and the "quantified self" offer new perspectives for data analytics. Regarding analytics, significant advances have been made in the information extraction from text data, which unlocks a lot of data from clinical documentation for analytics purposes. At the same time, medicine and healthcare is lagging behind in the adoption of Big Data approaches. This can be traced to particular problems regarding data complexity and organizational, legal, and ethical challenges. The growing uptake of Big Data in general and first best-practice examples in medicine and healthcare in particular, indicate that innovative solutions will be coming. This paper gives an overview of the potentials of Big Data in medicine and healthcare.


Asunto(s)
Confidencialidad/tendencias , Conjuntos de Datos como Asunto/tendencias , Atención a la Salud/tendencias , Registros Electrónicos de Salud/tendencias , Investigación sobre Servicios de Salud/tendencias , Vigilancia de la Población/métodos , Seguridad Computacional/tendencias , Minería de Datos/tendencias , Factores de Riesgo
6.
Ecancermedicalscience ; 8: 399, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24567756

RESUMEN

Usability testing methods are nowadays integrated into the design and development of health-care software, and the need for usability in health-care information technology (IT) is widely accepted by clinicians and researchers. Usability assessment starts with the identification of specific objectives that need to be tested and continues with the definition of evaluation criteria and monitoring procedures before usability tests are performed to assess the quality of all services and tasks. Such a process is implemented in the p-medicine environment and gives feedback iteratively to all software developers in the project. GCP (good clinical practice) criteria require additional usability testing of the software. For the p-medicine project (www.p-medicine.eu), an extended usability concept (EUC) was developed. The EUC covers topics like ease of use, likeability, and usefulness, usability in trial centres characterised by a mixed care and research environment and by extreme time constraints, confidentiality, use of source documents, standard operating procedures (SOA), and quality control during data handling to ensure that all data are reliable and have been processed correctly in terms of accuracy, completeness, legibility, consistence, and timeliness. Here, we describe the p-medicine EUC, focusing on two of the many key tools: ObTiMA and the Ontology Annotator (OA).

7.
Artículo en Inglés | MEDLINE | ID: mdl-24110412

RESUMEN

Clinical decision support (CDS) systems promise to improve the quality of clinical care by helping physicians to make better, more informed decisions efficiently. However, the design and testing of CDS systems for practical medical use is cumbersome. It has been recognized that this may easily lead to a problematic mismatch between the developers' idea of the system and requirements from clinical practice. In this paper, we will present an approach to reduce the complexity of constructing a CDS system. The approach is based on an ontological annotation of data resources, which improves standardization and the semantic processing of data. This, in turn, allows to use data mining tools to automatically create hypotheses for CDS models, which reduces the manual workload in the creation of a new model. The approach is implemented in the context of EU research project p-medicine. A proof of concept implementation on data from an existing Leukemia study is presented.


Asunto(s)
Sistemas de Apoyo a Decisiones Clínicas , Algoritmos , Minería de Datos , Técnicas de Apoyo para la Decisión , Humanos
8.
Stud Health Technol Inform ; 169: 734-8, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21893844

RESUMEN

The challenges regarding seamless integration of distributed, heterogeneous and multilevel data arising in the context of contemporary, post-genomic clinical trials cannot be effectively addressed with current methodologies. An urgent need exists to access data in a uniform manner, to share information among different clinical and research centers, and to store data in secure repositories assuring the privacy of patients. Advancing Clinico-Genomic Trials (ACGT) was a European Commission funded Integrated Project that aimed at providing tools and methods to enhance the efficiency of clinical trials in the -omics era. The project, now completed after four years of work, involved the development of both a set of methodological approaches as well as tools and services and its testing in the context of real-world clinico-genomic scenarios. This paper describes the main experiences using the ACGT platform and its tools within one such scenario and highlights the very promising results obtained.


Asunto(s)
Biología Computacional/organización & administración , Informática Médica/organización & administración , Investigación Biomédica , Ensayos Clínicos como Asunto , Sistemas de Computación , Computadores , Europa (Continente) , Genómica , Humanos , Neoplasias/genética , Desarrollo de Programa , Interfaz Usuario-Computador , Flujo de Trabajo
9.
Stud Health Technol Inform ; 147: 95-104, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19593048

RESUMEN

Grid technologies have proven to be very successful in the area of eScience, and healthcare in particular, because they allow to easily combine proven solutions for data querying, integration, and analysis into a secure, scalable framework. In order to integrate the services that implement these solutions into a given Grid architecture, some metadata is required, for example information about the low-level access to these services, security information, and some documentation for the user. In this paper, we investigate how relevant metadata can be extracted from a semi-structured textual documentation of the algorithm that is underlying the service, by the use of text mining methods. In particular, we investigate the semi-automatic conversion of functions of the statistical environment R into Grid services as implemented by the GridR tool by the generation of appropriate metadata.


Asunto(s)
Almacenamiento y Recuperación de la Información/métodos , Informática Médica/organización & administración , Algoritmos
10.
Stud Health Technol Inform ; 147: 277-82, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19593067

RESUMEN

Grid technologies have proven to be very successful in the area of eScience, and in particular in healthcare applications. But while the applicability of workflow enacting tools for biomedical research has long since been proven, the practical adoption into regular clinical research has some additional challenges in grid context. In this paper, we investigate the case of data monitoring, and how to seamlessly implement the step between a one-time proof-of-concept workflow and high-performance on-line monitoring of data streams, as exemplified by the case of long-running clinical trials. We will present an approach based on proxy services that allows executing single-run workflows repeatedly with little overhead.


Asunto(s)
Ensayos Clínicos como Asunto , Bases de Datos como Asunto/organización & administración , Eficiencia Organizacional , Genómica
11.
Stud Health Technol Inform ; 126: 184-93, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17476061

RESUMEN

Recent advances in research methods and technologies have resulted in an explosion of information and knowledge about cancers and their treatment. Knowledge Discovery (KD) is a key technique for dealing with this massive amount of data and the challenges of managing the steadily growing amount of available knowledge. In this paper, we present the ACGT integrated project, which is to contribute to the resolution of these problems by developing semantic grid services in support of multi-centric, post-genomic clinical trials. In particular, we describe the challenges of KD in clinico-genomic data in a collaborative Grid framework, and present our approach to overcome these difficulties by improving workflow management, construction and managing workflow results and provenance information. Our approach combines several techniques into a framework that is suitable to address the problems of interactivity and multiple dependencies between workflows, services, and data.


Asunto(s)
Informática Médica/organización & administración , Neoplasias/genética , Eficiencia Organizacional , Europa (Continente) , Humanos , Neoplasias/terapia , Semántica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA